Eurofins Scientific Nante (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ERFSF | TDOC | NVCR | AVTR | CRL |
| Company | Eurofins Scientific Nante | Teladoc Health Inc | Novocure Ltd Ord Sh | Avantor Inc | Charles River Laboratories Intl |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NYSE |
| Open | 62.4500 | 12.68 | 12.15 | 23.91 | 227.39 |
| High | 62.4500 | 13.60 | 12.65 | 24.44 | 230.86 |
| Low | 60.0000 | 12.65 | 12.01 | 23.40 | 227.39 |
| Last | 60.0000 | 13.01 | 12.64 | 23.94 | 229.03 |
| Change | -0.0100 | -0.32 | +0.41 | -1.21 | +1.22 |
| % Change | -0.02% | -2.40% | +3.31% | -4.81% | +0.54% |
| Volume | 1,200 | 7,696,700 | 762,100 | 14,185,100 | 322,100 |
| 20-Day Average Volume | 3,115 | 5,197,935 | 1,121,465 | 4,854,440 | 502,320 |
| Previous Close | 60.0100 | 13.33 | 12.23 | 25.15 | 227.81 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 63.6633 | 13.92 | 13.31 | 25.04 | 243.13 |
| 20-Day Raw Stochastic | 0.00% | 13.74% | 23.79% | 19.93% | 11.12% |
| 20-Day Relative Strength | 45.28% | 35.37% | 43.45% | 43.15% | 39.43% |
| Weighted Alpha | -11.80 | -44.53 | -66.38 | +22.39 | +17.93 |
| Today's Opinion | 32% Buy | 100% Sell | 72% Sell | 40% Buy | 24% Buy |
| Previous Opinion | 32% Buy | 100% Sell | 72% Sell | 96% Buy | 24% Buy |
| Last Month's Opinion | 80% Buy | 88% Sell | 40% Sell | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.34% since 04/19/24 | +0.23% since 04/19/24 | +4.51% since 04/19/24 | -0.66% since 04/19/24 | +0.99% since 04/19/24 |
| Low | 60.0000 on 04/26/24 | 12.65 on 04/26/24 | 11.70 on 04/23/24 | 23.40 on 04/26/24 | 225.79 on 04/22/24 |
| High | 68.4500 on 04/23/24 | 14.05 on 04/23/24 | 12.65 on 04/26/24 | 25.99 on 04/24/24 | 244.56 on 04/24/24 |
| 1-Month | |||||
| %Chg | -2.73% since 03/26/24 | -13.55% since 03/26/24 | -3.33% since 03/26/24 | -5.67% since 03/26/24 | -13.72% since 03/26/24 |
| Low | 60.0000 on 04/26/24 | 12.65 on 04/26/24 | 11.70 on 04/23/24 | 23.40 on 04/26/24 | 223.49 on 04/18/24 |
| High | 68.4500 on 04/23/24 | 15.43 on 03/28/24 | 16.05 on 03/28/24 | 26.11 on 04/09/24 | 273.32 on 04/01/24 |
| 3-Month | |||||
| %Chg | -1.98% since 01/26/24 | -35.63% since 01/26/24 | -11.08% since 01/26/24 | +5.65% since 01/26/24 | +3.97% since 01/26/24 |
| Low | 56.9100 on 02/02/24 | 12.65 on 04/26/24 | 11.70 on 04/23/24 | 21.68 on 02/13/24 | 212.52 on 02/01/24 |
| High | 68.4500 on 04/23/24 | 21.74 on 02/15/24 | 18.04 on 03/08/24 | 26.16 on 03/25/24 | 275.00 on 03/08/24 |
| 6-Month | |||||
| %Chg | +27.28% since 10/26/23 | -19.14% since 10/26/23 | -2.96% since 10/26/23 | +22.64% since 10/26/23 | +30.82% since 10/26/23 |
| Low | 47.9700 on 10/27/23 | 12.65 on 04/26/24 | 10.87 on 11/13/23 | 16.63 on 10/30/23 | 161.65 on 11/01/23 |
| High | 68.4500 on 04/23/24 | 22.54 on 01/02/24 | 18.04 on 03/08/24 | 26.16 on 03/25/24 | 275.00 on 03/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,550,064 | 2,256,956 | 1,316,021 | 17,058,768 | 11,734,721 |
| Shares Outstanding, K | 192,469 | 169,314 | 107,606 | 678,281 | 51,511 |
| Annual Sales | 7,050,590,000 | 2,602,420,000 | 509,340,000 | 6,967,200,000 | 4,129,410,000 |
| Annual Net Income | 335,490,000 | -220,370,000 | -207,040,000 | 321,100,000 | 474,620,000 |
| Last Quarter Sales | N/A | 660,530,000 | 133,780,000 | 1,722,800,000 | 1,013,480,000 |
| Last Quarter Net Income | N/A | -28,890,000 | -47,080,000 | 98,500,000 | 187,080,000 |
| 60-Month Beta | 0.73 | 0.94 | 0.42 | 1.37 | 1.40 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.49 on 04/25/24 | -0.45 on 02/22/24 | 0.25 on 02/14/24 | 2.46 on 02/14/24 |
| Latest Earnings Date | 05/28/24 | 04/25/24 | 05/02/24 | 04/26/24 | 05/09/24 |
| Most Recent Dividend | N/A | N/A | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | N/A | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | 23.79 | 22.48 |